Fig. 1From: Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?Timeline of publication of latest guidelines for FD and of disease-specific therapy approvals. As of December 31, 2017, agalsidase alfa was approved in 58 countries, excluding the USA. FD, Fabry diseaseBack to article page